Clinical Trials

NCT IdNCT04107740
TitleC-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
ConditionSpinocerebellar Degeneration
StudyTypeInterventional
OrganizationMediForum Pharm
Sponsor/CollaboratorsMediForum Pharm
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Chonnam National University Hospital, Gwangju, Korea, Republic of
  • Gangnam Severance Hospital, Seoul, Korea, Republic of
  • Korea University Anam Hospital, Seoul, Korea, Republic of
  • Korea University Guro Hospital, Seoul, Korea, Republic of
  • Samsung Medical Center, Seoul, Korea, Republic of
  • Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea, Republic of
  • Seoul National University Hospital, Seoul, Korea, Republic of
  • The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, Korea, Republic of
DescriptionThe aim of this study is to evaluate the efficacy and safety of C-Trelin OD Tablet 5mg(Taltirelin Hydrate) in randomized, double-blind, placebo-controlled clinical trial in patients with ataxia induced by spinocerebellar degeneration.